167 related articles for article (PubMed ID: 15830141)
1. Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.
Jäger R; Friedrichs N; Heim I; Büttner R; Schorle H
Breast Cancer Res Treat; 2005 Apr; 90(3):273-80. PubMed ID: 15830141
[TBL] [Abstract][Full Text] [Related]
2. The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis.
Park JM; Wu T; Cyr AR; Woodfield GW; De Andrade JP; Spanheimer PM; Li T; Sugg SL; Lal G; Domann FE; Zhang W; Weigel RJ
Oncogene; 2015 Dec; 34(50):6105-14. PubMed ID: 25772240
[TBL] [Abstract][Full Text] [Related]
3. Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer.
Li M; Wang Y; Hung MC; Kannan P
Int J Cancer; 2006 Feb; 118(4):802-11. PubMed ID: 16108032
[TBL] [Abstract][Full Text] [Related]
4. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.
Li B; Rosen JM; McMenamin-Balano J; Muller WJ; Perkins AS
Mol Cell Biol; 1997 Jun; 17(6):3155-63. PubMed ID: 9154814
[TBL] [Abstract][Full Text] [Related]
5. Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth.
Zhu CH; Domann FE
Breast Cancer Res Treat; 2002 Jan; 71(1):47-57. PubMed ID: 11859873
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
[TBL] [Abstract][Full Text] [Related]
7. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
Podsypanina K; Li Y; Varmus HE
BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
[TBL] [Abstract][Full Text] [Related]
8. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
9. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
Hutchinson JN; Jin J; Cardiff RD; Woodgett JR; Muller WJ
Cancer Res; 2004 May; 64(9):3171-8. PubMed ID: 15126356
[TBL] [Abstract][Full Text] [Related]
10. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T
Cancer Res; 1998 Dec; 58(23):5466-72. PubMed ID: 9850080
[TBL] [Abstract][Full Text] [Related]
11. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
12. Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.
Young CD; Nolte EC; Lewis A; Serkova NJ; Anderson SM
Breast Cancer Res; 2008; 10(4):R70. PubMed ID: 18700973
[TBL] [Abstract][Full Text] [Related]
13. Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer.
Friedrichs N; Jäger R; Paggen E; Rudlowski C; Merkelbach-Bruse S; Schorle H; Buettner R
Mod Pathol; 2005 Mar; 18(3):431-8. PubMed ID: 15467710
[TBL] [Abstract][Full Text] [Related]
14. [On the role of transcription factor family AP-2 for development and disease--lessons from mouse models].
Schorle H
Verh Dtsch Ges Pathol; 2007; 91():91-7. PubMed ID: 18314601
[TBL] [Abstract][Full Text] [Related]
15. Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.
Musgrove EA; Davison EA; Ormandy CJ
J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):55-66. PubMed ID: 15082918
[TBL] [Abstract][Full Text] [Related]
16. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma.
Bosher JM; Totty NF; Hsuan JJ; Williams T; Hurst HC
Oncogene; 1996 Oct; 13(8):1701-7. PubMed ID: 8895516
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model.
Jäger R; Werling U; Rimpf S; Jacob A; Schorle H
Mol Cancer Res; 2003 Oct; 1(12):921-9. PubMed ID: 14573793
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression.
Gillgrass A; Cardiff RD; Sharan N; Kannan S; Muller WJ
Oncogene; 2003 Dec; 22(57):9151-5. PubMed ID: 14668796
[TBL] [Abstract][Full Text] [Related]
19. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
[TBL] [Abstract][Full Text] [Related]
20. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
